Session Information
AABB Audioconference Series 2008
Click here to go to the previous page
Intravenous Immunoglobulin (IVIG): Intended Use and Administration
Track
:
TECHNICAL/CLINICAL
Program Code:
094564
Date:
Wednesday, October 22, 2008
Time:
2:00 PM to 3:30 PM
EST
DIRECTOR
:
Jennifer Rhamy, MBA, MA, MT(ASCP)SBB, HP, EXECUTIVE DIRECTOR, LABORATORY ACCREDITATION, THE JOINT COMMISSION
MODERATOR
:
Jennifer Rhamy, MBA, MA, MT(ASCP)SBB, HP, EXECUTIVE DIRECTOR, LABORATORY ACCREDITATION, THE JOINT COMMISSION
SPEAKER
(S):
Robert S. Makar, MD, PhD, Assistant Director, Blood Transfusion Service, Massachusetts General Hospital
Heather Hume, MD, FRCPC, Associate Clinical Professor, University of Montreal
Description
Intravenous Immunoglobulin (IVIG) is used increasingly for a broad number of disorders. The Canadian health system recently convened an expert panel to develop guidelines for use in hematological and neurological diseases. This audio conference will explore issues associated with the administration of the medicine including adverse effects.
LEARNER OUTCOMES:
- Describe issues associated with the administration of IVIG.
- List indications for the use for hematology and neurology patients.
- Name adverse effects associated with the medication.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |